Elisabetta Bianchi

7PUBLICATIONS
53CO-AUTHORS
Biologically active moleculesProteins and peptidesPharmaceutical delivery technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 01, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.

Douglas G Johns, Louis-Charles Campeau, Puja Banka

|Aug 18, 2022
Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity.

Chunhui Huang, Anandan Palani, Zhiqiang Yang

|Aug 18, 2022
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.

Anandan Palani, Andrea R Nawrocki, Federica Orvieto

|Dec 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain.

Gregory L Adams, Parul S Pall, Steven M Grauer

|Oct 27, 2021
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.

Thomas J Tucker, Mark W Embrey, Candice Alleyne

Pageof 2